Organisation: Novartis

Delhi High Court’s reversal of Novartis injunction provides further guidance on India’s controversial Section 3(d) requirement

Pendulum swings in favour of local generic drugmaker Natco in long-running Indian pharma dispute against Novartis

12 June 2024

USPTO sorting through comments on AI-assisted inventorship guidance

IBM, Qualcomm, Google, Amazon and Novartis agree that inventors must be humans but views vary on the legal test the USPTO is using

17 May 2024

FTC opposes 300 more Orange Book patents

The US Federal Trade Commission is ramping up pressure on pharma patentees

02 May 2024

GSK becomes latest mRNA patentee to enter covid IP wars, increasing pressure on Pfizer/BioNTech

Meanwhile BioNTech and Moderna face off in the UK, and another mRNA spat settles

29 April 2024

Apple, Google targeted at UPC; IPBC China; FTC non-compete ban; Meta patent transfer; Chinese automaker licence; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

28 April 2024

Alexion and Novartis/Genentech start UPC’s first ever biosimilar disputes

The patentees join Amgen as the only pharma companies yet to use the pan-European court

24 April 2024

A guide to ongoing biosimilar battles as Johnson & Johnson reaches Stelara settlement

IAM hones in on spats over several biologic drugs in Europe and beyond

08 April 2024

UPC judge on SEP policy; IPBC Europe; Infosys AI focus; India’s patent licensing plans; Boeing settlement; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

24 March 2024

Regeneron and Novartis dispute leads Second Circuit to reject creation of new patent standard

A lower court improperly invented a rule preventing plaintiffs from challenging anticompetitive harm to a market encompassed entirely by a patent, the US Court of Appeals for the Second Circuit has said

19 March 2024

mRNA firms and other biopharma patentees dominate ‘Innovation Momentum’ rankings

Newly released report throws light on which life sciences companies have the most dynamic IP portfolios

22 February 2024